Abstract
Peter Armitage CBE recently passed away (February 2024). He was a pio¬neer in medical statistics and was best known for his innovative developments in clinical trial design and analysis, especially the use of sequential analysis and optimal stopping decision criteria. Sequen¬tial analysis was originally devised as a tool for industrial quality control, and it was Armitage’s genius to recognize its importance for medical research. This column includes tributes and memories of Armitage’s life and accomplishments.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have